Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

NCT04623931 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Anaplastic Astrocytoma, IDH-Wildtype
Anaplastic Oligoastrocytoma
Anaplastic Oligodendroglioma
Diffuse Astrocytoma, IDH-Wildtype
Glioblastoma
Oligoastrocytoma
Oligodendroglioma
WHO Grade II Glioma
WHO Grade III Glioma

Interventions

OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
RADIATION: Radiation Therapy
DRUG: Temozolomide

Sponsor

M.D. Anderson Cancer Center